Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Status:
Terminated
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying samples of blood from patients with cancer, hepatitis C, or Crohn disease
in the laboratory may help doctors learn more about changes that occur in DNA and identify
biomarkers related to cancer and other diseases.
PURPOSE: This laboratory study is looking at the effect of biological therapy on biomarkers
in patients with untreated hepatitis C, metastatic melanoma, or Crohn disease.